The news of DDReg announcing its collaboration with Quantiphi has been featured in numerous leading news publications and media pages. This is an exciting chapter as it’s the first time Artificial Intelligence is going to be used in navigating regulatory complexities in the pharmaceutical and biotechnology landscape across the globe.
Quantiphi, a global AI-first digital engineering company, is a leader in artificial intelligence and machine learning and collaborating with them opens a world of possibilities for life sciences industry to address the challenges in ever-evolving regulation landscape. As we continue to evolve, our goal is simple- to make regulatory affairs smarter, faster, and more efficient for the global pharmaceutical industry. And this partnership is a big step in that direction.
DDReg is humbled by the attention this partnership is receiving, having been featured by over 200 media channels. This widespread coverage reflects the dedication, commitment, and shared global vision between DDReg and Quantiphi in transforming the regulatory landscape by leveraging regulatory expertise, capabilities, and technological disruptors like AI that are paving the way for digitalization in pharma.
The team of DDReg looks forward to showing the real-world impact of this collaboration
in making regulatory processes easier, more efficient, and ultimately more human.
